消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2026 APSPGHAN意见书：儿童炎症性肠病（PIBD）的诊断——对亚太地区的影响

2026-01-29 Pediatr Gastroenterol Hepatol Nutr 发表于上海

儿童炎症性肠病

在整个亚太地区，儿童炎症性肠病（PIBD）的发病率显著增加。本文旨在全面回顾亚太地区诊断PIBD所面临的挑战，并根据特定地区的文献提供实用建议。

中文标题：

2026 APSPGHAN意见书：儿童炎症性肠病（PIBD）的诊断——对亚太地区的影响

英文标题：

Diagnosis of Pediatric Inflammatory Bowel Disease (PIBD)-Implications for the Asia-Pacific Region: A Position Paper from the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition PIBD Working Group

发布机构：

发布日期：

2026-01-29

简要介绍：

在整个亚太地区，儿童炎症性肠病（PIBD）的发病率显著增加。本文旨在全面回顾亚太地区诊断PIBD所面临的挑战，并根据特定地区的文献提供实用建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2026 APSPGHAN意见书：儿童炎症性肠病（PIBD）的诊断——对亚太地区的影响.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a6cbd1c00a913603, title=2026 APSPGHAN意见书：儿童炎症性肠病（PIBD）的诊断——对亚太地区的影响, enTitle=Diagnosis of Pediatric Inflammatory Bowel Disease (PIBD)-Implications for the Asia-Pacific Region: A Position Paper from the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition PIBD Working Group, guiderFrom=Pediatr Gastroenterol Hepatol Nutr, authorId=0, author=, summary=在整个亚太地区，儿童炎症性肠病（PIBD）的发病率显著增加。本文旨在全面回顾亚太地区诊断PIBD所面临的挑战，并根据特定地区的文献提供实用建议。, cover=https://img.medsci.cn/20260127/1769515102926_8538692.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Jan 29 00:00:00 CST 2026, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight summary" style="color: #222222;" data-lines="12"><span class="text">在整个亚太地区，儿童炎症性肠病（PIBD）的发病率显著增加。本文旨在全面回顾亚太地区诊断PIBD所面临的挑战，并根据特定地区的文献提供实用建议。</span></div> </div>, tagList=[TagDto(tagId=457907, tagName=儿童炎症性肠病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=457907, articleKeyword=儿童炎症性肠病, articleKeywordNum=6, guiderKeywordId=457907, guiderKeyword=儿童炎症性肠病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=659, appHits=7, showAppHits=0, pcHits=29, showPcHits=652, likes=0, shares=3, comments=0, approvalStatus=1, publishedTime=Thu Feb 05 08:13:00 CST 2026, publishedTimeString=2026-01-29, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 04 16:09:56 CST 2026, updatedBy=8538692, updatedName=梅斯平台小助手, updatedTime=Wed Feb 04 20:16:52 CST 2026, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2026 APSPGHAN意见书：儿童炎症性肠病（PIBD）的诊断——对亚太地区的影响.pdf)])
2026 APSPGHAN意见书：儿童炎症性肠病（PIBD）的诊断——对亚太地区的影响.pdf
下载请点击：
评论区 (0)
#插入话题

相关指南

2025 NASPGHAN意见书：儿童炎症性肠病的治疗药物监测

北美小儿胃肠病、肝脏病和营养学会(NASPGHAN,North American society for pediatric gastroenterology,Hepatology,and nutrition) · 2025-07-21

2020 NASPGHAN意见书：儿童炎症性肠病患者贫血

北美小儿胃肠病、肝脏病和营养学会(NASPGHAN,North American society for pediatric gastroenterology,Hepatology,and nutrition) · 2020-09-20

拓展阅读

儿童炎症性肠病治疗新方向：小分子药物如何推动精准医疗？

小分子药物为儿童炎症性肠病治疗打开了新窗口，但其全面发展仍需时间与数据的沉淀。

2020 NASPGHAN意见书：儿童炎症性肠病患者贫血

北美小儿胃肠病、肝脏病和营养学会(NASPGHAN,North American society for pediatric gastroenterology,Hepatology,and nutrition) · 2020-09-20

2025 NASPGHAN意见书：儿童炎症性肠病的治疗药物监测

北美小儿胃肠病、肝脏病和营养学会(NASPGHAN,North American society for pediatric gastroenterology,Hepatology,and nutrition) · 2025-07-21